Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B-cell depleting therapy

Benkert, P (author)

Maceski, AM (author)

Schadelin, S (author)

show more...

Willemse, E (author)

Meier, S (author)

Melie-Garcia, L (author)

Cagol, A (author)

Galbusera, R (author)

Subramaniam, S (author)

Lorscheider, J (author)

Fischer-Barnicol, B (author)

Achtnichts, L (author)

Findling, O (author)

Lalive, P (author)

Bridel, C (author)

Muller, S (author)

Pot, C (author)

Mathias, A (author)

Du Pasquier, R (author)

Salmen, A (author)

Hoepner, R (author)

Chan, A (author)

Disanto, G (author)

Zecca, C (author)

Orleth, A (author)

DSouza, M (author)

Yaldizli, O (author)

Derfuss, T (author)

Oechtering, J (author)

Gobbi, C (author)

Khalil, M (author)

Abdelhak, A (author)

Oksenberg, JR (author)

Hermesdorf, M (author)

Berger, K (author)

Wiendl, H (author)

Piehl, F (author)

Conen, D (author)

Buser, A (author)

Kappos, L (author)

Granziera, C (author)

Leppert, D (author)

Kuhle, J (author)

show less...

2023

2023

English.

In: MULTIPLE SCLEROSIS JOURNAL. - 1352-4585. ; 29, s. 58-60

Related links:

http://kipublication...

• Conference paper (other academic/artistic)